Navigation Links
Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells
Date:12/10/2008

Published in the Journal Blood for the American Society of Hematology Annual Meeting

SOMERSET, N.J., Dec. 10 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today announced that American Society of Hematology (ASH) annual meeting abstracts in Blood (2008 112: Abstract 4205 & 2008 112: Abstract 4010) report that ONCONASE (ranpirnase) and R-Amphinase (R-Amph) show anti-tumor activity in chronic lymphocytic leukemia (CLL) and acute myeloblastic leukemia (AML) cells alone as well as in combination with standard chemotherapeutic agents, expanding the spectrum of malignancies for which Alfacell's proprietary ribonucleases show promising activity.

The abstracts are the result of research conducted by collaborators at the Department of Hematology, Medical University of Lodz in Poland, Alfacell and the Brander Cancer Research Institute and Department of Pathology at New York Medical College. ONCONASE and R-Amph are amphibian endoribonucleases with unique mechanisms of inhibiting the growth and causing apoptosis (programmed cell death) of malignant cells. Previously, ONCONASE has been shown to affect multiple cellular pathways involved in these mechanisms, and has been validated in many solid tumor cell lines, as well as a T-cell leukemia cell line. These reports now broaden ONCONASE's activity into CLL and AML, and include a related endoribonuclease, R-Amph.

For the study in CLL, leukemic cells were isolated from 36 untreated patients with CLL and were cultured for 24-72 hours with either ONCONASE or R-Amph alone and in combination with the purine analogues cladribine (2-CdA) and fludarabine (FA), as well as with doxorubicin. A significant cytotoxic effect of ONCONASE and R-Amph was evident after 48 and 72 hours of treatment, respectively. Synergistic activity was seen in th
'/>"/>

SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
2. Paper in Cell Cycle Reports Alfacells ONCONASE(R) Targets siRNA
3. New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties
4. Celator(R) Pharmaceuticals Study Shows CPX-571 Maintains Synergistic Ratio of Irinotecan and Cisplatin to Improve Anti-tumor Activity
5. Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
6. ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer
7. CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux).
8. Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist
9. Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Institute (NEI), a division of the National Institutes of Health ... help fund its development of a non-invasive, passive diffusion-based treatment ... ... Salt Lake City, UT (PRWEB) December 10, 2009 ... National Institutes of Health (NIH), awarded a $2.18 million grant ...
(Date:12/10/2009)... 10 Newly published research, by ... Cell Institute (NESCI) in the journal STEM ... eight patients with "Limbal Stem Cell Deficiency" ... without the need of suppressing their immunity. ... LSCD is a painful, blinding disease that ...
(Date:12/10/2009)... flow measurement, control, and level solutions, announced that ... Level Product Manager effective November 30, 2009. He ... penetration of the level measurement products around the ... Corp, a manufacturer of building materials, where he ... will report to Brooks Instrument Vice President Tim ...
(Date:12/10/2009)... CORALVILLE, Iowa, Dec. 10 Vivakor, ... that it has entered into an exclusive, ... specialist, Regeneca International, Inc. ( www.regeneca.com ). ... distribution rights to a new cutting-edge nutraceutical ... the development of future formulations by Vivakor ...
Breaking Biology Technology:NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3Successful Stem Cell Therapy for Treatment of Eye Disease 2Successful Stem Cell Therapy for Treatment of Eye Disease 3Successful Stem Cell Therapy for Treatment of Eye Disease 4Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3
... 30 BREAKING NEWS: Paige Padgett has,been selected as ... Annual,Environmental Media Awards on November 13th at The Ebell ... members., Blush, lipstick, eye shadow - check. Ecological ... "green" or eco-conscious often doesn,t,happen in the bathroom. Up ...
... to revolutionize,endoscopic surgery, LAS VEGAS, Oct. 30 ... of women,s healthcare with the presentation of gynecologic ... "4K" technology, at the 37th,Global Congress of Minimally ... international professional society for specialists in minimally,invasive gynecological ...
... (Nasdaq: PCYC ) today reported financial results for ... loss for the first quarter of,fiscal 2009, was $6.5 ... loss,of $6.8 million, or $0.26 per share, in the ... were $6.6 million in the first quarter of,fiscal 2009, ...
Other Biology Technology:Green Makeup Artist Paige Padgett Says, 'Get Smart' 2Women's Surgery Recorded for the First Time on '4K' Digital Cinema is Presented at the AAGL Congress 2Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results 2Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results 3Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results 4Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results 5
(Date:12/14/2009)... 10, 2009If you are spending the holidays with big ... you would be better off with another family, spare ... A research team from McMaster University and the University ... a species that lives in groups, members make strategic ... appear in the current issue of Biology Letters ...
(Date:12/14/2009)... tool use as a defining feature of humans. That,s until ... with birds and an array of other mammals. Now, a ... , a Cell Press publication, adds an octopus to the ... study manages a behavioral trick that the researchers call stilt ... upright coconut shell "bowls," makes its eight arms rigid, and ...
(Date:12/14/2009)... Technology Partners, a global software company that automates ... the Pharmaceutical industry, today announced the general availability ... data acquisition platform. The latest release enables quality ... manufacturing processes. ,, MODA 3.0 includes the ... Methods: Each test method in the MODA ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2US Farms Inc Launches New Aloe Vera Skin Gel Product 51874 1US Farms Inc Launches New Aloe Vera Skin Gel Product 51874 2US Farms Inc Launches New Aloe Vera Skin Gel Product 51874 3Raptor Pharmaceuticals Corp to Present at 2009 Cystinosis Research Network Family Conference 51871 1Raptor Pharmaceuticals Corp to Present at 2009 Cystinosis Research Network Family Conference 51871 2Raptor Pharmaceuticals Corp to Present at 2009 Cystinosis Research Network Family Conference 51871 3Raptor Pharmaceuticals Corp to Present at 2009 Cystinosis Research Network Family Conference 51871 4Raptor Pharmaceuticals Corp to Present at 2009 Cystinosis Research Network Family Conference 51871 5AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 1AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 2AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 3
... or ARF, is as serious as it sounds. An estimated ... their death rate range from 50% to 80%, complicated by ... of other major organ systems. , The most serious form ... supply to the kidneys caused by shock, blood infection or ...
... pet rescue organizations are growing in number, working ... Although the majority of these organizations operate out ... winning high visibility for placing their pooches. , ... of the American Sociological Association (ASA) in Philadelphia, ...
... have designed world-first technology to investigate sustainable energy ... high-pressure bacteria from deep sediments. , Scientists and ... deep sediments which despite high pressures (greater than ... 2°C to over 100°C), great depth (several kilometres) ...
Other Biology News:Stem cells bring fast direct improvement, without differentiation, in acute renal failure 2Stem cells bring fast direct improvement, without differentiation, in acute renal failure 3Stem cells bring fast direct improvement, without differentiation, in acute renal failure 4Stem cells bring fast direct improvement, without differentiation, in acute renal failure 5Virtual animal shelters ?How the Internet is transforming the experience of pet adoptions 2World-first technology enables study of ancient bacteria 2
Heavy-duty rim. Especially recommended as a titration flask. Corning5100. capacity 250 mL Special grade: student grade...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (F1676) or contact customer s...
Mouse monoclonal [YPF19] to Yersinia pestis F1 antigen ( Abpromise for all tested applications)....
... number is a new product number, ... number. If showing no availability yet, ... number (E6152) or contact customer service ... diam. 11.25 6.40 in. ...
Biology Products: